Efficacy and safety of alogliptin in a pediatric patient with maturity-onset diabetes of the young type 1-Reference-Cited by-同舟云学术

Efficacy and safety of alogliptin in a pediatric patient with maturity-onset diabetes of the young type 1

Published:2017 Issue:3 Volume:26 Page:183-188
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Tonouchi Ryosuke¹,Mine Yusuke¹,Aoki Masako¹,Okuno Misako¹,Suzuki Junichi¹,Urakami Tatsuhiko¹

Affiliation:

1. Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/26/3/26_2017-0007/_pdf

Reference22 articles.

1. 1. Andersen, G, Hansen, T, Pedersen, O. Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track?Curr Mol Med 2005;5: 261–74.

2. 2. Gat-Yablonski, G, Shalitin, S, Phillip, M. Maturity onset diabetes of the youngreview. Pediatr Endocrinol Rev 2006;3(Suppl 3): 514–20.

3. 3. Kavvoura, FK, Owen, KR. Maturity onset diabetes of the young: clinical characteristics, diagnosis and management. Pediatr Endocrinol Rev 2012;10: 234–42.

4. 4. Stoffel, M, Duncan, SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997;94: 13209–14.

5. 5. Pearson, ER, Boj, SF, Steele, AM, Barrett, T, Stals, K, Shield, JP, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007;4: e118.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics in children with maturity-onset diabetes of the young detected by urine glucose screening at schools in the Tokyo Metropolitan Area;CLIN PEDIATR ENDOCRI;2024

2. Clinical characteristics in children with maturity-onset diabetes of the young detected by urine glucose screening at schools in the Tokyo Metropolitan Area;Clinical Pediatric Endocrinology;2024

3. Advancements in pharmacotherapy options for treating diabetes ‎in children and adolescents;Expert Review of Endocrinology & Metabolism;2023-12-11

4. Diagnose und Behandlung des Maturity-Onset Diabetes of the Young (MODY);Diabetologie und Stoffwechsel;2021-10

5. Alogliptin: efficiency, safety, new possibilities;Meditsinskiy sovet = Medical Council;2020-05-29